Renowned Speakers

Wenhua Ling

Sun Yat-Sen University China

Damien Byas

Center for Healthcare and Organizational Research, USA USA

Jeko Madjarov Carolinas Healthcare Syste

Carolinas Healthcare System Pineville USA

Mila Jakovljevic Polyclinic for Cardiova

Polyclinic for Cardiovascular Diseases and Prevention Croatia

Jacob Ostrowsky

Rainbow Babies & Children’s Hospital USA

Aris Lacis

Children’s Clinical University Hospital Latvia

Marc-Alexander Ohlow

Zentralklinik Bad Berka Germany

Mark Caulfield

William Harvey Research Institute & Queen Mary University of London UK

Recommended Global Cardiology Webinars & Conferences

Europe & UK

World Cardiology Summit 2020, Spain World Cardiology 2020, Italy World Cancer-2021, Germany Hypertension 2020, Germany

Asia Pacific & Middle East

WHC 2020, Australia WCCCT 2020, Japan Rare Disease 2020, UAE Heart Summit 2020, Japan

Canada

Pediatric Cardiology 2020, Canada Heart Congress 2020, Canada Cardiac Surgery 2020, Canada Annual Cardiology 2020, Canada

Heart Conference 2020

About Conference

Conference Series llc Ltd. is inviting all participants across the globe to attend 6^th world congress on october19-20,2020, prague,Czech Republic. This Cardiology Conference will bring together world-class professors, scientists and cardiologists to discuss Clinical Cardiolog y,vardio vascular, cardio Auscultaton,cardiac nursing , cardiac Toxicity, heart sounds, Cardiology, Cardiovascular Surgery, Hypertension and Health care, cardiology patients simulator,carotid arteries , Cardiac Pharmacology, developmental origins of health & diseases, cardiovascular safely trail, cardiomyoplasty, cardiac mapping, Nutrition, Diet & Exercise, Cardiac and Cardiovascular Research, Heart Devices and Diabetes, Obesity & Stroke

Heart Congress 2020 is designed to provide diverse and current education that will keep cardiology professionals a breast of the issues affecting the prevention, diagnosis and treatment of cardiovascular disease. The conference will be organized around the theme "Gathering the Newborn Advances in Cardiology”.

Heart Congress 2020 aims to provide an opportunity to share knowledge, expertise along with unparalleled networking opportunities between a large number of medical professionals like Directors, Heads, Deans, Professors, Scientists, Researchers, Cardiologists, Founders and Employees of the related companies, Associations, Organizations, Laboratory members and Young researchers working in the field of Cardiology & Heart treatment. This Cardiology conference mainly focuses on spreading the awareness about challenges in this fields and how to prevent and manage the techniques of Cardiac Imaging, Cardiology and Cardiac nursing.

Conference Series llc Ltd. Organizes 300+ conferences, 500+workshops and 200+symposiums on Clinical, Medicine, Nursing, cardiology diagnosis workshops, cardiac nursing conferences, Cardiology Conferences ,Heart conferences and Science & Technology every year across USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more scientific societies and Publishes 500 open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Why to attend??

Encounter the target market with members from across the globe, committed to learn about Cardiology techniques. This is the best opportunity to outreach the largest gathering of participants from around the world. Conduct presentations, distribute and update knowledge about the current situation of nuclear cardiology & echocardiography technique and receive name recognition at this 2-days event. World-eminent speakers, most recent researches, latest treatment techniques and the advanced updates in Nuclear Cardiology are the principal features of Cardiology Conferences

Target Audience:

Our Organization would be privileged to welcome the:

Directors of Cardiology and related Programs or Associations

Heads, Deans and Professors of Cardiology and related departments

Scientists and Researchers

Cardiology Associations and Organizations

Laboratory members and Students working in the field of Cardiology.

Session/Tracks

TRACK 1: Cardiology

Cardiology is a division of medicine which deals with the study of disorders of the heart as well as parts of the circulatory system. This field holds medical diagnosis and treatment of cognetial heart defects. Cardiologists are medical doctors who specialize in heart and blood vessel disease. They help in preventing the disease as well as diagnose and treat those who previously have them. Cardiology is circulated into numerous fields such as pediatric cardiology, adult cardiology, interventional procedures, electrophysiology and echocardiography etc.

Related Cardiology Conferences: 5th World Congress on Cardiology and Cardiovascular Therapeutics, August 12-13, 2019 Tokyo, Japan | Asian Global Summit on Heart and Emergency Medicine, November 01-02, 2019 Kyoto, Japan | International Conference on Hypertension and lifestyle disorders, November 25-26, 2019 Yokohama, Japan | International Conference on, Cardiology and Heart Failure, December 02-03, 2019 Tokyo, Japan |27th International Conference & Exhibition on, Cardiology and Cardiovascular Medicine, July 26-27, 2019 Kyoto, Japan

Major Cardiology Societies / Associations:

TRACK 2: Cardiovascular development

The process of developing of the heart and the vascular system which is often called together as a cardiovascular system, with the heart being the first functional organ which forms in the embryo. The heart that forms initially in the embryonic disc is as a simple combined tube inside the forming pericardial cavity, which when the disc folds, carried into the correct anatomical place in the chest cavity. The Improvement begins at very early in the mesoderm both within (embryonic) and outside the extra embryonic, yolk sac and placental the embryo.

Major Cardiology Societies / Associations:

TRACK 3: Pediatric cardiology

Pediatric cardiology is a division of medicine deals with heart associated problems in new born, infants, children and adolescents. A pediatric cardiologist is a pediatrician who has acknowledged extensive training in diagnosing and treating children's cardiac problems. Currently, evaluating and treating the disease condition may begin with the fetus since heart problems can now be noticed before birth. Hence this division is actively involved in therapeutic conclusion and treatment of preventing both congenital and acquired heart disease in children. Finally, the division is committed to educating the next generation of physicians and offers advanced training in pediatric cardiology.

Major Cardiology Societies / Associations:

TRACK 4: Cardiac nursing

Cardiac nursing is a field nursing that works with patients who practice the ill effects of different states of the cardiovascular system. A cardiac care nurse or cardiac nurse is an expertise who cares definitely for patients with heart issues. While the obligations and duties of a nurse with this title may change from situation to situation, they will treat patients who have experienced or endure different sorts of heart problems under the direction of cardiologists. They perform various tasks such as performing stress tests, care for a patient after an operation, complete health assessments or closely monitor the patient’s heart rate.

Major Cardiology Societies / Associations:

TRACK 5: Heart diseases

Heart disease describes a range of conditions that interrupt the heart. Diseases under the heart disease includes blood vessel diseases, such as coronary artery disease; heart rhythm problems (arrhythmias); and heart defects you're born with (congenital heart defects), among others. Heart disease term is frequently used interchangeably with the cardiovascular disease. It generally refers to conditions that involve narrowed or blocked blood vessels that can lead to a heart failure, chest pain (angina) or stroke. Other heart circumstances, such as those that affect your heart's muscle, valves or rhythm, also are considered forms of heart disease. Many forms of heart disease can be prohibited or treated with healthy lifestyle choices.

Cerebrovascular disease
Inflammatory heart disease
Hypertensive heart disease
Ischemic heart disease
Rheumatic heart disease
Acute heart failure
Acute heart failure
Diabetes mellitus and cardiovascular diseases
Heart defects

Major Cardiology Societies / Associations:

TRACK 7: C ardiac Surgery

Cardiac surgery, also called heart surgery, involves surgical operations made on the heart under to correct life-threatening conditions. The surgery can be either open-heart surgery or minimally invasive surgery subject on the condition to be corrected. The purpose of cardiac surgery is to progress the quality of life of the patient and to extend the patient's lifespan. Cardiac surgery includes substantial risk and is only done when the benefits outweigh the risk. Risks are highest for infants under one year of age and adults over age 60. Risk increases with age and when the individual has other health problems such as diabetes, chronic kidney failure, chronic lung disease, pulmonary edema, congestive heart failure, electrolyte imbalances, alcoholism, and prior history of heart attack or stroke. Even though few circumstances categorically rule out a cardiac process, the physician must judge the risks and benefits on an individual basis.

Major Cardiology Societies / Associations:

TRACK 8: Cardiovascular pharmacology

Cardiovascular pharmacology deals with the medicine of cardiac diseases. The Cardiac Drugs are used to treat conditions of the heart or the circulatory or vascular system. Many classes of cardiovascular agents are existing to treat the numerous cardiovascular conditions. In this sub topic we have Sodium, potassium, calcium network blockers, ACE-inhibitors and cardiac biomarkers. There are six associations and societies and the main association for Cardiac Therapeutic Agents in USA. 50 universities are working on Cardiac Therapeutic Agents. Three new drugs were announced in 2015. There are many types of cardiovascular drugs in the market that hold Cardiac glycosides, anti-coagulants, anti-arrhythmic agents, anti-anginal agents and anti-hypertensive agents.

Major Cardiology Societies / Associations:

TRACK 9: Heart devices

Heart disease defines a variety of conditions that disturb the heart. Diseases under the heart disease includes blood vessel diseases, such as coronary artery disease; heart rhythm problems (arrhythamias); and heart defects you're born with (congenital heart defects), among others. Heart disease term is frequently used interchangeably with the cardiovascular disease. It generally refers to conditions that include narrowed or blocked blood vessels that can lead to a heart failure, chest pain (angina) or stroke. Other heart conditions, such as those that affect your heart's muscle, valves or rhythm, also are considered methods of heart disease. Many forms of heart disease can be disallowed or treated with healthy lifestyle choices.

Cerebrovascular disease
Inflammatory heart disease
Hypertensive heart disease
Ischemic heart disease
Rheumatic heart disease
Acute heart failure
Acute heart failure
Diabetes mellitus and cardiovascular diseases
Heart defects

Major Cardiology Societies / Associations:

TRACK 10: Advances in cardiology

Advances in cardiology contain the current research and new innovative methods that are emerging in the field of cardiology and its related fields. Advanced research in this field allows early detection of CHD in order to halt or reverse the progress of the disease. It focuses on the research related to devices, development of Nuclear Cardiology methods for the detection of heart disease, drug development and evaluation of treatments used in heart disease, identification of novel biological markers to predict the presence of heart disease etc.

Major Cardiology Societies / Associations:

Market Analysis

Top five drivers of cardiovascular market growth

Total sales for cardiovascular diseases will grow steadily over the next six years, reaching about $60B in 2023. The top five major drivers of this growth will be two anticoagulants (Bristol-Myers Squibb’s [BMS’] Eliquis [apixaban] and Johnson & Johnson [J&J]/Bayer’s Xarelto [rivaroxaban]), a heart failure drug (Novartis’s Entresto [sacubitril/valsartan]) and two drugs for pulmonary arterial hypertension (J&J’s Opsumit [macitentan] and Uptravi [selexipag]). These five drugs will represent 50% of the total cardiovascular market in 2023, while Eliquis and Xarelto alone will represent 36% of the whole cardiovascular market. Cholesterol-lowering drugs were not part of this analysis, as they were considered to be part of the metabolic disorders therapeutic area.

Governments are trying to limit hospital readmissions to reduce the prevalence of hospital acquired infections (HAIs) by imposing penalties on hospitals. As a result, adoption of home healthcare, remote patient monitoring, and long term care services is rapidly increasing. Thus, demand for cardiovascular devices is increasing from hospitals, patients based in home settings, and long term care centers. In addition, favorable government policies such as reimbursement coverage are fueling adoption of these devices. Thus, increasing target patient population, rising acceptance of home healthcare, and favorable government policies are some of the major factors driving the growth of the global cardiovascular devices market.

On the other hand, high device cost and stringent regulatory approval procedure are some of the prime factors challenging the growth of the market. In addition, lack of skilled professionals to perform surgical procedures using advanced devices is impeding the adoption of new devices. The global cardiac monitoring market is expected to register a CAGR of around 4%. North America accounted for the highest market value in 2017. However, Middle East & Africa is expected to register the highest CAGR during the forecast period. Cardiovascular diseases have become one of the primary reasons for mortality and are becoming a major concern in most parts of the world. Coronary heart disease (CHD) is the most common type of heart disease, with a death toll of more than 370,000 people annually. The American Heart Association (AHA) reports cardiovascular disease to be the leading global cause of death, accounting for 17.3 million deaths per year, a number that is expected to grow to more than 23.6 million by 2030. The Heart Foundation also states that CVD is a major cause of death in Australia, with 45,053 deaths attributed to CVD in the country, in 2014.

Segment 1: ECG Systems| Segment 2: Hoter Monitors Segment

3: Implantable Loop Recorders| Segment 4: Others

Past Conference Report

Heart Conference 2019

Past Reports Gallery

To Collaborate Scientific Professionals around the World

Conference Date October 19-20, 2020

For Sponsors & Exhibitors

[email protected]eries.com

Speaker Opportunity

Day 1

Poster Opportunity E-Poster Opportunity

Useful Links

Past Conference Report

Heart Conference 2019 Gallery Heart Conference 2019 Conference

Supported By

Journal of Interventional and General Cardiology Interventional Cardiology Journal Journal of Clinical Cardiology and Research

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by

6^th World Heart Congress

October 19-20, 2020 Webinar

Gathering the Newborn Advances in Cardiology

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Renowned Speakers

Wenhua Ling

Damien Byas

Jeko Madjarov Carolinas Healthcare Syste

Mila Jakovljevic Polyclinic for Cardiova

Jacob Ostrowsky

Aris Lacis

Marc-Alexander Ohlow

Mark Caulfield

Recommended Global Cardiology Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

Heart Conference 2020

About Conference

Session/Tracks

Market Analysis

Past Conference Report

To Collaborate Scientific Professionals around the World

Useful Links

Past Conference Report

Supported By

Keytopics